Skip to main content

NewAmsterdam Pharma Co N.V.

NAMS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001936258

In the last 90 days, NewAmsterdam Pharma Co N.V. insiders filed 1 open-market purchase and 3 sales; 194 institutions reported holding it in 13F filings for Q2 2026, worth $4.13B in total; 3 superinvestors hold it, including Viking Global Investors and Maverick Capital.

Other share classesNAMSW

Superinvestors holding NAMS, Q2 2026

3 superinvestors report holding NewAmsterdam Pharma Co N.V. on Form 13F, worth $357.3M in total. Weight is NewAmsterdam Pharma Co N.V.'s share of each 13F portfolio; actions compare shares with Q1 2026.

See all superinvestors
Superinvestors holding NAMS in Q2 2026
Superinvestor% of portfolioSharesValuevs. previous quarter
Viking Global InvestorsAndreas Halvorsen0.4%4,203,567$142.5MUnchanged
Maverick CapitalLee Ainslie1.0%3,267,802$110.7MAdded+49.5%
Duquesne Family OfficeStanley Druckenmiller2.4%3,070,146$104.0MUnchanged

Moves by quarter

Superinvestors that opened, added to, trimmed or sold out of NAMS each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.

  1. Q2 2026

    3 superinvestors holding at quarter end

    Added
    Maverick Capital (+49.5%)
  2. Q1 2026

    3 superinvestors holding at quarter end

    Added
    Maverick Capital (+15.4%)
  3. Q4 2025

    3 superinvestors holding at quarter end

    Added
    Duquesne Family Office (+59.6%), Maverick Capital (+25.9%)
    Reduced
    Viking Global Investors (−35.1%)
  4. Q3 2025

    3 superinvestors holding at quarter end

    Added
    Duquesne Family Office (+131.2%)
    Reduced
    Viking Global Investors (−7.2%), Maverick Capital (−1.8%)
  5. Q2 2025

    3 superinvestors holding at quarter end

    Added
    Maverick Capital (+178.8%), Duquesne Family Office (+4.0%)
  6. Q1 2025

    3 superinvestors holding at quarter end

    Added
    Duquesne Family Office (+178.4%), Maverick Capital (+57.0%)
  7. Q4 2024

    3 superinvestors holding at quarter end

    New
    Maverick Capital
    Reduced
    Viking Global Investors (−13.0%)
  8. Q3 2024

    2 superinvestors holding at quarter end

    New
    Duquesne Family Office
  9. Q3 2023

    1 superinvestor holding at quarter end

    Added
    Viking Global Investors (+23.0%)
  10. Q2 2023

    1 superinvestor holding at quarter end

    Added
    Viking Global Investors (+66.6%)
  11. Q1 2023

    1 superinvestor holding at quarter end

    Added
    Viking Global Investors (+4.3%)
  12. Q4 2022

    1 superinvestor holding at quarter end

    New
    Viking Global Investors